A New Era In Management Of Traumatic Disruptions Of The Thoracic Aorta
Main Category: VascularAlso Included In: Cardiovascular / Cardiology
Article Date: 24 Nov 2008 - 9:00 PDT
| Patient / Public: | ![]() | |
| Healthcare Prof: | ![]() |
Traumatic disruptions of the thoracic aorta are often life-threatening, and traditional open repair carries the risks of significant morbidity and mortality. These patients routinely have multiple injuries that make a classic thoracotomy a serious and difficult operation.
As presented by Edward B. Diethrich, M.D., Medical Director and Chief of Cardiovascular & Thoracic Surgery at the Arizona Heart Institute & Hospital in Phoenix, following the Food and Drug Administration (FDA) approval of multiple endografts, a new era in the management of these lesions has begun in the United States.
Deployment of an endograft across the transection may be done under local anesthesia and greatly reduces the risk of the operation, while also permitting clinicians time to direct attention toward resolving other life-threatening conditions.
A major problem, however, is that there is currently no commercial devices approved for this application.
Numerous trials are now enrolling patients to answer questions about extending the indications for these devices to include acute transection due to deceleration injury.
Per Dr. Diethrich: "Because the risks associated with an open thoracotomy are considerable, in general, we regard the minimally invasive endovascular approach the 'goldstandard' treatment for acute transection at our institution."
VEITH SYMPOSIUM - New York, November 19th to 23rd
Now in its fourth decade, VEITH SYMPOSIUM provides vascular surgeons, interventional radiologists, interventional cardiologists and other vascular specialists with a unique and exciting format to learn the most current information about what is new and important in the treatment of vascular disease. The 5-day event features rapid-fire presentations from world renowned vascular specialists with emphasis on the latest advances, changing concepts in diagnosis and management, pressing controversies and new techniques.
VEITHsymposium is sponsored by Cleveland Clinic, Cleveland, OH.
www.veithsymposium.org
Source
Pauline T. Mayer
www.ptmhcm.com
Visit our vascular section for the latest news on this subject.
MLA
16 Feb. 2012. <http://www.medicalnewstoday.com/releases/130523.php>
APA
http://www.medicalnewstoday.com/releases/130523.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.



